Share this post on:

Product Name :
Diroximel fumarate

Search keywords :
NFE2

drugId :
null

Target Vo:
Nuclear factor erythroid 2-related factor 2

Target Vo Short Name :
Nrf2

Moa_Name:
Nuclear factor erythroid 2-related factor 2 stimulants

First Approval Country :
United States

First Approval Date Filter:
2019

Origin Company_Name :
Alkermes Plc

Active Company_Name :
Alkermes Pharma Ireland Ltd

Active Indication_Name:
Multiple Sclerosis, Relapsing-Remitting

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Caspase-14 Antibody
Phospho-EGFR (Tyr1068) Antibody
PDGFR alpha Antibody: PDGFR alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 123 kDa, targeting to PDGFR alpha. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Betaine hydrochloride